 Home > Biochemistry News > Biotechnology News > Over $600 million!

Over $600 million!

 Last Update: 2022-02-24
 Source: Internet
 Author: User

Tags

dry ingredients

cell organ

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Author: Bai Lu

On December 20, Lineage Cell Therapeutics announced that it has signed an exclusive global collaboration and license agreement with its subsidiary Cell Cure Neurosciences and Roche subsidiary Genentech to jointly develop and commercialize retinal pigment epithelium (RPE) cell therapies for the treatment of eye diseases, Including advanced dry age-related macular degeneration (AMD) with geographic atrophy (GA)

Genentech will be responsible for further clinical development and commercialization of Lineage's OpRegen® program, which is currently being evaluated in a Phase I/IIa open-label, dose-escalation clinical safety and efficacy study in patients with advanced dry AMD and GA

OpRegen® is an allogeneic RPE cell transplantation therapy

References:

1# Retinal Tissue Restored in Patients with Dry AMD, Heralding Paradigm Shift (Source: BioSpace)

2# Roche adds to Genentech's ophthalmology program with $670M in biobucks for Lineage Cell Therapeutics' asset (Source: FIERCE Biotech)

3# LINEAGE ESTABLISHES EXCLUSIVE WORLDWIDE COLLABORATION WITH GENENTECH FOR THE DEVELOPMENT AND COMMERCIALIZATION OFOPREGEN® RPE CELL THERAPY FOR THE TREATMENT OF OCULAR DISORDERS (Source: Lineage Cell Therapeutics official website)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Over 600 million US dollars!

10-10

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

Over $600 million!

Related Articles

Over 600 million US dollars!